published in Leukemia Lymphoma. ⢠Would the next step be :Imaging in ... lymphoma subtypes (FL,MCL,T-lymphoma ). 3. Identify key area of research in ...
International workshops on PET in lymphoma History and Perspective Michel Meignan, Créteil, France Aaron Polliack, Jerusalem, Israel
First international workshop on interim PET In Lymphoma April 3-4, 2009, Deauville, France (M Meignan, A Gallamini, C Haioun)
54 registered
Nuclear medicine and Hematologists are moving forward together!!!
Second international workshop on interim PET in Lymphoma April 8-9, 2010, Menton, France (M Meignan, A Gallamini, C Haioun)
143 registered
December 2010; 51(12):2171-80
The last meeting
2012;53:1876-81
195 registered 23 countries
Since the 2011 meeting
• IVS in Hodgkin Lymphoma accepted in Journal of Nuclear Medicine • IVS in DLBCL presented at the meeting of the Society of Nuclear Medicine June 2012
Since the 2011 meeting • Web site http://eitti.free.fr 6000-8000 hits , 1GB download per month
What’s new in the organization?
LYSA Imaging
FIL Imaging committee
• The 5th workshop will be held in September 2014 and then every two years-end of summer or early autumn in September or October • Will take place between two ICML (Lugano). • In the interval it will extended by dedicated activities (during ICML and Society of Nuclear Medicine meetings?).
What’s new in the program? • Interim PET in Lymphoma has moved to PET in Lymphoma • Posters selected for presentation to be published in Leukemia Lymphoma • Would the next step be :Imaging in Lymphoma / and Myeloma ?
Aim of the present meeting 1.
Prepare the « Staging and Response assesment » consensus for the 12th ICML (Lugano, June 2013)
2.
Present new data on the role of PET in other lymphoma subtypes (FL,MCL,T-lymphoma )
3.
Identify key area of research in lymphoma imaging (Metabolic volume)
4.
Establish a link between this meeting and SNM meetings and ICML
FDG-PET after 2 cycles appears highly predictive, particularly for ... features (bulk, 3+ sites). ⢠All prognostic ... Assumptions: â 75% PET-negative after 2 ABVD.
Apr 9, 2010 - Haematology Torino and Rome. Second International workshop ... >No concomitant cardiac, liver, lung or renal disease. >HIV negativity, HCV ...
Staging and risk assessment of marginal zone lymphoma: ââ¦The value of positron emission ... MALT originating from the left lacrimal gland. PET-CT in MALT ...
if + (scores 4-5) or equivocal (score 3) then PET after 2 ABVD cycle. ⢠N=199 HL. 54 I-IIA .... Baseline MTV predictive of PFS and OS although tumor bulk was not.
Apr 8, 2010 - Positivity/Reference background. â¢Nearby background. â¢Mediastinal blood pool ... On which curve is this patient? Significance of minimal ...
Therapy ABVD or EBVD x 6 ± consolidation or IF radiotherapy. Visual assessment: ... LYMPHOMA. 44 HIV-related HL patients enrolled in 9 European centers.
3rd International Workshop on Interim PET in Lymphoma. Menton, September 27, 2011. Poster Discussion. Poster discussion. NHL. Ulrich Dührsen. Department ...
The five-point visual assessment is applied as proposed at the Deauville consensus meeting. ⢠A cohort of ABVD-treated advanced-stage HL patients has been ...
Various Rent-A-Car Companies can be found in the airport such as: Ada, Avis, Budget, Europcar, Hertz,. National Citer and Sixt. ⢠13 connections by regular bus ...
A 110 - Mounier N, Bower M, Spina M, Besson C, Schiantarelli C, Re A Bonnet F ..... Medicine Unit, Ospedale Policlinico, Padova; (7) Nuclear Medicine Unit, Ospedale La ...... Results: The average (median) time per scan upload and download.
Apr 8, 2010 - PET-positive after two courses of. ABVD and comparison of RT on prior bulk versus no RT in PET-negative patients at the end of chemotherapy.
Second international workshop on interim-PET in lymphoma. Menton (France), Palais de l'Europe, April 8-9th, 2010. Under the auspices of GELA, IIL, EORTC, ...
Sep 25, 2011 - lymphoma, new radiotracers and new imaging modalities. ⢠Evolving drugs: the era of targeted therapy could change the way we use PET ...
